Related Experiment Video
Updated: Apr 4, 2026
09:10
The Lower Body Positive Pressure Treadmill for Knee Osteoarthritis Rehabilitation
Published on: July 22, 2019
11.4K
Treadmill training for patients with Parkinson's disease
Jan Mehrholz1, Joachim Kugler, Alexander Storch
1Wissenschaftliches Institut, Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH, An der Wolfsschlucht 1-2, Kreischa, Germany, 01731.
The Cochrane Database of Systematic Reviews
|September 14, 2015
Summary
Treadmill training shows potential for improving gait speed and stride length in Parkinson's disease patients. This therapy appears beneficial and safe, though long-term effects and optimal protocols require further investigation.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Movement Disorders
Background:
- Treadmill training is a common rehabilitation technique.
- It is suggested to enhance gait parameters in individuals with Parkinson's disease.
Purpose of the Study:
- To evaluate the efficacy of treadmill training for improving gait in Parkinson's disease patients.
- To assess the safety and acceptability of this therapeutic approach.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials.
- Searched multiple databases including Cochrane, MEDLINE, and EMBASE up to September 2014.
- Included 18 trials with 633 participants comparing treadmill training to no training.
Main Results:
- Treadmill training significantly improved gait speed (MD = 0.09 m/s) and stride length (MD = 0.05 m).
- Improvements in walking distance and cadence were not statistically significant.
- Treadmill training did not increase dropout rates, and adverse events were not reported.
Conclusions:
- Treadmill training offers moderate to low-quality evidence for improving key gait parameters in Parkinson's disease.
- While beneficial for gait speed and stride length, effects on other parameters are less clear.
- The therapy appears safe and potentially more effective than standard physiotherapy for gait hypokinesia, but results warrant cautious interpretation due to heterogeneity and limited long-term data.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K